Promethazine vs. Lorazepam for Treatment of Vertigo

Peripheral Vertigo. Clinical Trial

Official title: Promethazine vs. Lorazepam for Treatment of Vertigo in the Emergency Department: A Randomized Clinical Trial

Status Completed

Clinical Trial Summary

This study was a prospective, randomized, double-blind, parallel group clinical trial designed to compare the efficacy of intravenous (IV) promethazine and lorazepam for the treatment of peripheral vertigo in Emergency Department setting.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Dizziness
• Peripheral Vertigo.
• Vertigo

• NCT number: NCT01827293
• Study type: Interventional
• Source: hahid Beheshti University of Medical Sciences
• Status: Completed
• Phase: Phase 3
• Start date: April 2013
• Completion date: June 2013